Loading Pathway...
Error: Pathway image not found.
Hide
Pathway Description
Samarium (153Sm) lexidronam Drug Metabolism
Homo sapiens
Metabolic Pathway
Samarium (153Sm) lexidronam is a drug that is not metabolized by the human body as determined by current research and biotransformer analysis. Samarium (153Sm) lexidronam passes through the liver and is then excreted from the body mainly through the kidney.
References
Samarium (153Sm) lexidronam Drug Metabolism References
Wishart DS, Feunang YD, Guo AC, Lo EJ, Marcu A, Grant JR, Sajed T, Johnson D, Li C, Sayeeda Z, Assempour N, Iynkkaran I, Liu Y, Maciejewski A, Gale N, Wilson A, Chin L, Cummings R, Le D, Pon A, Knox C, Wilson M: DrugBank 5.0: a major update to the DrugBank database for 2018. Nucleic Acids Res. 2018 Jan 4;46(D1):D1074-D1082. doi: 10.1093/nar/gkx1037.
Pubmed: 29126136
Wishart DS, Tian S, Allen D, Oler E, Peters H, Lui VW, Gautam V, Djoumbou Feunang Y, Greiner R, Metz TO; BioTransformer 3.0 – A Web Server for Accurately Predicting Metabolic Transformation Products [Submitted in Nucleic Acids Research, Webserver Issue.Apr.2022]
Highlighted elements will appear in red.
Highlight Compounds
Highlight Proteins
Enter relative concentration values (without units). Elements will be highlighted in a color gradient where red = lowest concentration and green = highest concentration. For the best results, view the pathway in Black and White.
Visualize Compound Data
Visualize Protein Data
Downloads
Settings